Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report
Anatara Lifesciences (ASX:ANR) today released its Appendix 4C financial report for the quarter ending 31st March 2018.
Companies in the News
Biotech
Queensland Bauxite Ltd (ASX:QBL) VitaHemp Releases Its "Black Label" Premium Hemp Seed Oil Soft Gel Capsules
The Board of Queensland Bauxite (ASX:QBL) are pleased to advise that Medical Cannabis Limited through its subsidiary VitaHemp Pty Ltd, has announced the release of a very first to market, Australian grown and processed Hemp Seed Oil soft-gel capsules.
Nanollose Ltd (ASX:NC6) Letter to Shareholders
Nanollose Ltd (ASX:NC6) on 16 April 2018, lodged a Prospectus with ASIC and ASX, seeking to raise up to approximately $187,500 by a non-renounceable rights offer of up to approximately 18,749,999 entitlement options on the basis of 1 entitlement option for every 4 shares held at an issue price of 1 cent per entitlement option.
Queensland Bauxite Ltd (ASX:QBL) MCL First to Release Australian Hemp Seed Oil Capsules
The Board of Queensland Bauxite (ASX:QBL) is pleased to advise that Medical Cannabis Limited through its subsidiary VitaHemp Pty Ltd, is announcing the release of a first of its kind to the Australian market, Australian grown and processed Hemp Seed Oil soft-gel capsules.
Nanollose Ltd (ASX:NC6) Letter to Optionholders
Nanollose Ltd (ASX:NC6) on 16 April 2018, lodged a Prospectus with ASIC and ASX, seeking to raise up to approximately $187,500 by a non-renounceable rights offer of up to approximately 18,749,999 entitlement options on the basis of 1 entitlement option for every 4 shares held at an issue price of 1 cent per entitlement option.
Nanollose Ltd (ASX:NC6) to Present at TechKnow Invest Roadshow
Nanollose Limited (ASX:NC6) is pleased to announce that the Company will be presenting at the TechKnow Invest Roadshow in Sydney on Tuesday 10th April 2018 (today) and Melbourne on Thursday 12th April 2018.
Nanollose Ltd (ASX:NC6) Dr Wayne Best Appointed Executive Chairman
Nanollose Limited (ASX:NC6) is pleased to announce that as the Company enters a new phase of commercialisation and development, Dr Wayne Best will increase his involvement across research and development and assist in the effort to prioritise and convert numerous opportunities currently being presented to the Company.
◂Previous Page
Biotech Next Page▸
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Basin Energy Ltd (ASX:BSN) Drilling Contractors Engaged for Sybella-Barkly Targets
- State Gas Limited (ASX:GAS) Quarterly Activities Report
- Basin Energy Ltd (ASX:BSN) Quarterly Activities Report
- Central Petroleum Limited (ASX:CTP) Quarterly Activities Report
- Basin Energy Ltd (ASX:BSN) Queensland Uranium and Rare Earth Acquisition Completed
- VIDEO: Beetaloo Energy Australia Limited (ASX:BTL) Quarterly Activities Report 30 September and Interview with MD Alex Underwood
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Test for Endometriosis Receives $0.5m Grant
- VIDEO: Proteomics International Laboratories Ltd (ASX:PIQ) Interview with Managing Director Dr. Richard Lipscombe
- BPH Energy Limited (ASX:BPH) September Quarter Operations Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Quarterly Activities Report
- Proteomics International Laboratories Ltd (ASX:PIQ) Collaboration expanded to advance Endometriosis blood test
- Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of Director
Social Media
